Determinants and Prognostic Significance of an Intra-dialysis Rise of Cardiac Troponin I Measured by Sensitive Assay in Hemodialysis Patients

Overview

Journal Clin Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 2013 Feb 12

PMID 23397594

Citations 4

Authors

Solmaz Assa

Ron T Gansevoort

Ralf Westerhuis

Anneke C Muller Kobold

Adriaan A Voors

Paul E de Jong

Stephan J L Bakker

Casper F M Franssen

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies using conventional cTnI assays reported conflicting results on the evolution of cTnI levels during hemodialysis. The determinants and prognostic significance of changes in cTnI during hemodialysis are presently unknown. The aim of this prospective study was to characterize the determinants and prognostic significance of intra-dialysis changes in cTnI using a sensitive assay.

Methods: cTnI was measured before and after hemodialysis with a sensitive assay in 90 chronic patients without acute cardiac symptoms. Multivariable regression analyses were used to identify factors that were associated with intra-dialysis rise in cTnI. The prognostic effect of an intra-dialysis rise in cTnI during a 52-month follow-up was evaluated using Cox regression models. The primary and secondary endpoint was the incidence of major adverse cardiovascular events and all-cause mortality, respectively.

Results: Pre-dialysis cTnI was elevated in 31 patients (34 %). cTnI increased significantly during dialysis and this had a trend to be associated with longer dialysis vintage. A greater intra-dialysis rise in cTnI was associated with a significantly higher incidence of cardiovascular events, also after correction for age, gender, dialysis vintage, residual diuresis, previous cardiovascular events, and pre-dialysis cTnI levels (HR per 10 ng/L rise in cTnI: 1.21; CI 1.06-1.38; p 0.005).

Conclusion: TnI levels rise significantly during hemodialysis and a greater intra-dialysis rise in cTnI is associated with an increased incidence of cardiovascular events. These findings suggest that hemodialysis has an acute deleterious effect on the heart. An intra-dialysis rise in cTnI may help identify patients who are susceptible to the hemodynamic stress of hemodialysis.

Citing Articles

Evolution of high-sensitivity troponin-T and echocardiography parameters in patients undergoing high efficiency on-line hemodiafiltration versus conventional low-flux hemodialysis.

Ethier I, Auger D, Beaulieu M, Wesolowska E, Levesque R PLoS One. 2019; 14(10):e0223957.

PMID: 31639150 PMC: 6804981. DOI: 10.1371/journal.pone.0223957.

High sensitivity Troponin-I levels in asymptomatic hemodialysis patients.

Tarapan T, Musikatavorn K, Phairatwet P, Takkavatakarn K, Susantitaphong P, Eiam-Ong S Ren Fail. 2019; 41(1):393-400.

PMID: 31132904 PMC: 6542185. DOI: 10.1080/0886022X.2019.1603110.

Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.

Poppelaars F, Gaya DA Costa M, Faria B, Berger S, Assa S, Daha M Front Immunol. 2018; 9:2070.

PMID: 30271407 PMC: 6146103. DOI: 10.3389/fimmu.2018.02070.

Serum cardiac troponin T and effective blood flow in stable extracorporeal dialysis patients.

Grzegorzewska A, Cieszynski K, Niepolski L, Kaczmarek A, Sowinska A Int Urol Nephrol. 2015; 48(3):419-29.

PMID: 26603871 PMC: 4769722. DOI: 10.1007/s11255-015-1165-z.

References

Metra M, Bettari L, Pagani F, Lazzarini V, Lombardi C, Carubelli V . Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Clin Res Cardiol. 2012; 101(8):663-72. DOI: 10.1007/s00392-012-0441-5. View

Apple F, Pearce L, Smith S, Kaczmarek J, Murakami M . Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem. 2009; 55(5):930-7. DOI: 10.1373/clinchem.2008.114728. View

Gaiki M, DeVita M, Michelis M, Panagopoulos G, Rosenstock J . Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay. Int Urol Nephrol. 2012; 44(6):1841-5. DOI: 10.1007/s11255-012-0128-x. View

Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S . Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009; 361(9):858-67. DOI: 10.1056/NEJMoa0900428. View

Assa S, Hummel Y, Voors A, Kuipers J, Westerhuis R, de Jong P . Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. Clin J Am Soc Nephrol. 2012; 7(10):1615-23. PMC: 3463203. DOI: 10.2215/CJN.00850112. View

Assa S, Dasselaar J, Slart R, de Jong P, Voors A, Tio R . Comparison of cardiac positron emission tomography perfusion defects during stress induced by hemodialysis versus adenosine. Am J Kidney Dis. 2012; 59(6):862-4. DOI: 10.1053/j.ajkd.2012.01.018. View

Farkouh M, Robbins M, Urooj Zafar M, Shimbo D, Davidson K, Puttappa R . Association between troponin I levels and mortality in stable hemodialysis patients. Am J Med. 2003; 114(3):224-6. DOI: 10.1016/s0002-9343(02)01482-1. View

Deleaval P, Descombes E, Magnin J, Martin P, Fellay G . [Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays]. Nephrol Ther. 2006; 2(2):75-81. DOI: 10.1016/j.nephro.2005.11.003. View

Iliou M, Fumeron C, Benoit M, Tuppin P, Courvoisier C, Calonge V . Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant. 2001; 16(7):1452-8. DOI: 10.1093/ndt/16.7.1452. View

10.

Yee-Moon Wang A, Lai K . Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol. 2008; 19(9):1643-52. DOI: 10.1681/ASN.2008010012. View

11.

McIntyre C . Effects of hemodialysis on cardiac function. Kidney Int. 2009; 76(4):371-5. DOI: 10.1038/ki.2009.207. View

12.

Tun A, Khan I, Win M, Hussain A, Hla T, Wattanasuwan N . Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers. Cardiology. 1999; 90(4):280-5. DOI: 10.1159/000006859. View

13.

Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, Meissner J . Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J. 2011; 33(8):988-97. DOI: 10.1093/eurheartj/ehr376. View

14.

Burton J, Jefferies H, Selby N, McIntyre C . Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol. 2009; 4(5):914-20. PMC: 2676185. DOI: 10.2215/CJN.03900808. View

15.

Celik S, Giannitsis E, Wollert K, Schwobel K, Lossnitzer D, Hilbel T . Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol. 2011; 100(12):1077-85. DOI: 10.1007/s00392-011-0344-x. View

16.

Troyanov S, Ly Q, Schampaert E, AMMANN H, Lalumiere G, Madore F . Diagnostic specificity and prognostic value of cardiac troponins in asymptomatic chronic haemodialysis patients: a three year prospective study. Heart. 2005; 91(9):1227-8. PMC: 1769112. DOI: 10.1136/hrt.2004.051219. View

17.

Ritz E, Rambausek M, Mall G, Ruffmann K, Mandelbaum A . Cardiac changes in uraemia and their possible relationship to cardiovascular instability on dialysis. Nephrol Dial Transplant. 1990; 5 Suppl 1:93-7. DOI: 10.1093/ndt/5.suppl_1.93. View

18.

Kumar N, Michelis M, DeVita M, Panagopoulos G, Rosenstock J . Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant. 2010; 26(2):665-70. DOI: 10.1093/ndt/gfq442. View

19.

Mueller M, Celik S, Biener M, Vafaie M, Schwoebel K, Wollert K . Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol. 2012; 101(10):837-45. DOI: 10.1007/s00392-012-0469-6. View

20.

Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D . Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000; 46(9):1345-50. View